{"id":"https://openalex.org/W1978434864","doi":"https://doi.org/10.1158/0008-5472.sabcs10-s3-3","title":"Abstract S3-3: First Results of the NeoALTTO Trial (BIG 01-06/EGF 106903): A Phase III, Randomized, Open Label, Neoadjuvant Study of Lapatinib, Trastuzumab, and Their Combination Plus Paclitaxel in Women with HER2-Positive Primary Breast Cancer","display_name":"Abstract S3-3: First Results of the NeoALTTO Trial (BIG 01-06/EGF 106903): A Phase III, Randomized, Open Label, Neoadjuvant Study of Lapatinib, Trastuzumab, and Their Combination Plus Paclitaxel in Women with HER2-Positive Primary Breast Cancer","publication_year":2010,"publication_date":"2010-12-01","ids":{"openalex":"https://openalex.org/W1978434864","doi":"https://doi.org/10.1158/0008-5472.sabcs10-s3-3","mag":"1978434864"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.sabcs10-s3-3","doi":"https://doi.org/10.1158/0008-5472.sabcs10-s3-3","is_oa":false,"landing_page_url":"https://doi.org/10.1158/0008-5472.sabcs10-s3-3","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5004300577","display_name":"Jose M Baselga","orcid":"https://orcid.org/0000-0003-1361-4063","observed_orcids":["https://orcid.org/0000-0003-1361-4063"]},"institutions":[{"id":"https://openalex.org/I2801838318","display_name":"Institut Jules Bordet","ror":"https://ror.org/05e8s8534","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2801838318"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210123325","display_name":"Instituto Nacional de Enfermedades Neopl\u00e1sicas","ror":"https://ror.org/03674y156","country_code":"PE","type":"healthcare","lineage":["https://openalex.org/I4210123325"]},{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]},{"id":"https://openalex.org/I4210158999","display_name":"National Cheng Kung University Hospital","ror":"https://ror.org/04zx3rq17","country_code":"TW","type":"healthcare","lineage":["https://openalex.org/I4210158999"]}],"countries":["BE","ES","PE","TW","US"],"is_corresponding":false,"raw_author_name":"J Baselga","raw_affiliation_strings":["on Behalf of the NeoALTTO Study Team. Vall d'Hebron University Hospital, Barcelona, Spain; FSS Ltd, Kincraig, United Kingdom; University Hospital Kiel, Germany; Breast Cancer Center Vall d'Hebron University Hospital and SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Institut Jules Bordet and Breast European Adjuvant Study Team, Brussels, Belgium; Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru; Breast International Group, Brussels, Belgium; SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Breast European Adjuvant Study Team, Brussels, Belgium; GlaxoSmithKline, Collegeville, PA; European Institute of Oncology, Milan, Italy; National Cheng Kung University Hospital, Tainan, Taiwan; National Institute of Oncology, Budapest, Hungary; Academic Hospital of the University Charite, Berlin, Germany; Dana-Farber Cancer Institute, Boston, MA; Institut Jules Bordet, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"on Behalf of the NeoALTTO Study Team. Vall d'Hebron University Hospital, Barcelona, Spain; FSS Ltd, Kincraig, United Kingdom; University Hospital Kiel, Germany; Breast Cancer Center Vall d'Hebron University Hospital and SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Institut Jules Bordet and Breast European Adjuvant Study Team, Brussels, Belgium; Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru; Breast International Group, Brussels, Belgium; SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Breast European Adjuvant Study Team, Brussels, Belgium; GlaxoSmithKline, Collegeville, PA; European Institute of Oncology, Milan, Italy; National Cheng Kung University Hospital, Tainan, Taiwan; National Institute of Oncology, Budapest, Hungary; Academic Hospital of the University Charite, Berlin, Germany; Dana-Farber Cancer Institute, Boston, MA; Institut Jules Bordet, Brussels, Belgium","institution_ids":["https://openalex.org/I2801838318","https://openalex.org/I4210117453","https://openalex.org/I4210123325","https://openalex.org/I4210127641","https://openalex.org/I4210158999"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039372242","display_name":"Ian Bradbury","orcid":"https://orcid.org/0000-0002-8152-4943","observed_orcids":["https://orcid.org/0000-0002-8152-4943"]},"institutions":[{"id":"https://openalex.org/I2801838318","display_name":"Institut Jules Bordet","ror":"https://ror.org/05e8s8534","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2801838318"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210123325","display_name":"Instituto Nacional de Enfermedades Neopl\u00e1sicas","ror":"https://ror.org/03674y156","country_code":"PE","type":"healthcare","lineage":["https://openalex.org/I4210123325"]},{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]},{"id":"https://openalex.org/I4210158999","display_name":"National Cheng Kung University Hospital","ror":"https://ror.org/04zx3rq17","country_code":"TW","type":"healthcare","lineage":["https://openalex.org/I4210158999"]}],"countries":["BE","ES","PE","TW","US"],"is_corresponding":false,"raw_author_name":"I Bradbury","raw_affiliation_strings":["on Behalf of the NeoALTTO Study Team. Vall d'Hebron University Hospital, Barcelona, Spain; FSS Ltd, Kincraig, United Kingdom; University Hospital Kiel, Germany; Breast Cancer Center Vall d'Hebron University Hospital and SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Institut Jules Bordet and Breast European Adjuvant Study Team, Brussels, Belgium; Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru; Breast International Group, Brussels, Belgium; SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Breast European Adjuvant Study Team, Brussels, Belgium; GlaxoSmithKline, Collegeville, PA; European Institute of Oncology, Milan, Italy; National Cheng Kung University Hospital, Tainan, Taiwan; National Institute of Oncology, Budapest, Hungary; Academic Hospital of the University Charite, Berlin, Germany; Dana-Farber Cancer Institute, Boston, MA; Institut Jules Bordet, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"on Behalf of the NeoALTTO Study Team. Vall d'Hebron University Hospital, Barcelona, Spain; FSS Ltd, Kincraig, United Kingdom; University Hospital Kiel, Germany; Breast Cancer Center Vall d'Hebron University Hospital and SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Institut Jules Bordet and Breast European Adjuvant Study Team, Brussels, Belgium; Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru; Breast International Group, Brussels, Belgium; SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Breast European Adjuvant Study Team, Brussels, Belgium; GlaxoSmithKline, Collegeville, PA; European Institute of Oncology, Milan, Italy; National Cheng Kung University Hospital, Tainan, Taiwan; National Institute of Oncology, Budapest, Hungary; Academic Hospital of the University Charite, Berlin, Germany; Dana-Farber Cancer Institute, Boston, MA; Institut Jules Bordet, Brussels, Belgium","institution_ids":["https://openalex.org/I2801838318","https://openalex.org/I4210117453","https://openalex.org/I4210123325","https://openalex.org/I4210127641","https://openalex.org/I4210158999"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071658752","display_name":"Holger Eidtmann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801838318","display_name":"Institut Jules Bordet","ror":"https://ror.org/05e8s8534","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2801838318"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210123325","display_name":"Instituto Nacional de Enfermedades Neopl\u00e1sicas","ror":"https://ror.org/03674y156","country_code":"PE","type":"healthcare","lineage":["https://openalex.org/I4210123325"]},{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]},{"id":"https://openalex.org/I4210158999","display_name":"National Cheng Kung University Hospital","ror":"https://ror.org/04zx3rq17","country_code":"TW","type":"healthcare","lineage":["https://openalex.org/I4210158999"]}],"countries":["BE","ES","PE","TW","US"],"is_corresponding":false,"raw_author_name":"H Eidtmann","raw_affiliation_strings":["on Behalf of the NeoALTTO Study Team. Vall d'Hebron University Hospital, Barcelona, Spain; FSS Ltd, Kincraig, United Kingdom; University Hospital Kiel, Germany; Breast Cancer Center Vall d'Hebron University Hospital and SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Institut Jules Bordet and Breast European Adjuvant Study Team, Brussels, Belgium; Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru; Breast International Group, Brussels, Belgium; SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Breast European Adjuvant Study Team, Brussels, Belgium; GlaxoSmithKline, Collegeville, PA; European Institute of Oncology, Milan, Italy; National Cheng Kung University Hospital, Tainan, Taiwan; National Institute of Oncology, Budapest, Hungary; Academic Hospital of the University Charite, Berlin, Germany; Dana-Farber Cancer Institute, Boston, MA; Institut Jules Bordet, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"on Behalf of the NeoALTTO Study Team. Vall d'Hebron University Hospital, Barcelona, Spain; FSS Ltd, Kincraig, United Kingdom; University Hospital Kiel, Germany; Breast Cancer Center Vall d'Hebron University Hospital and SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Institut Jules Bordet and Breast European Adjuvant Study Team, Brussels, Belgium; Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru; Breast International Group, Brussels, Belgium; SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Breast European Adjuvant Study Team, Brussels, Belgium; GlaxoSmithKline, Collegeville, PA; European Institute of Oncology, Milan, Italy; National Cheng Kung University Hospital, Tainan, Taiwan; National Institute of Oncology, Budapest, Hungary; Academic Hospital of the University Charite, Berlin, Germany; Dana-Farber Cancer Institute, Boston, MA; Institut Jules Bordet, Brussels, Belgium","institution_ids":["https://openalex.org/I2801838318","https://openalex.org/I4210117453","https://openalex.org/I4210123325","https://openalex.org/I4210127641","https://openalex.org/I4210158999"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001910485","display_name":"Serena Di Cosimo","orcid":"https://orcid.org/0000-0002-4666-8052","observed_orcids":["https://orcid.org/0000-0002-4666-8052"]},"institutions":[{"id":"https://openalex.org/I2801838318","display_name":"Institut Jules Bordet","ror":"https://ror.org/05e8s8534","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2801838318"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210123325","display_name":"Instituto Nacional de Enfermedades Neopl\u00e1sicas","ror":"https://ror.org/03674y156","country_code":"PE","type":"healthcare","lineage":["https://openalex.org/I4210123325"]},{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]},{"id":"https://openalex.org/I4210158999","display_name":"National Cheng Kung University Hospital","ror":"https://ror.org/04zx3rq17","country_code":"TW","type":"healthcare","lineage":["https://openalex.org/I4210158999"]}],"countries":["BE","ES","PE","TW","US"],"is_corresponding":false,"raw_author_name":"S Di Cosimo","raw_affiliation_strings":["on Behalf of the NeoALTTO Study Team. Vall d'Hebron University Hospital, Barcelona, Spain; FSS Ltd, Kincraig, United Kingdom; University Hospital Kiel, Germany; Breast Cancer Center Vall d'Hebron University Hospital and SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Institut Jules Bordet and Breast European Adjuvant Study Team, Brussels, Belgium; Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru; Breast International Group, Brussels, Belgium; SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Breast European Adjuvant Study Team, Brussels, Belgium; GlaxoSmithKline, Collegeville, PA; European Institute of Oncology, Milan, Italy; National Cheng Kung University Hospital, Tainan, Taiwan; National Institute of Oncology, Budapest, Hungary; Academic Hospital of the University Charite, Berlin, Germany; Dana-Farber Cancer Institute, Boston, MA; Institut Jules Bordet, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"on Behalf of the NeoALTTO Study Team. Vall d'Hebron University Hospital, Barcelona, Spain; FSS Ltd, Kincraig, United Kingdom; University Hospital Kiel, Germany; Breast Cancer Center Vall d'Hebron University Hospital and SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Institut Jules Bordet and Breast European Adjuvant Study Team, Brussels, Belgium; Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru; Breast International Group, Brussels, Belgium; SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Breast European Adjuvant Study Team, Brussels, Belgium; GlaxoSmithKline, Collegeville, PA; European Institute of Oncology, Milan, Italy; National Cheng Kung University Hospital, Tainan, Taiwan; National Institute of Oncology, Budapest, Hungary; Academic Hospital of the University Charite, Berlin, Germany; Dana-Farber Cancer Institute, Boston, MA; Institut Jules Bordet, Brussels, Belgium","institution_ids":["https://openalex.org/I2801838318","https://openalex.org/I4210117453","https://openalex.org/I4210123325","https://openalex.org/I4210127641","https://openalex.org/I4210158999"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112498455","display_name":"Claudia Monica Aura","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801838318","display_name":"Institut Jules Bordet","ror":"https://ror.org/05e8s8534","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2801838318"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210123325","display_name":"Instituto Nacional de Enfermedades Neopl\u00e1sicas","ror":"https://ror.org/03674y156","country_code":"PE","type":"healthcare","lineage":["https://openalex.org/I4210123325"]},{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]},{"id":"https://openalex.org/I4210158999","display_name":"National Cheng Kung University Hospital","ror":"https://ror.org/04zx3rq17","country_code":"TW","type":"healthcare","lineage":["https://openalex.org/I4210158999"]}],"countries":["BE","ES","PE","TW","US"],"is_corresponding":false,"raw_author_name":"C Aura","raw_affiliation_strings":["on Behalf of the NeoALTTO Study Team. Vall d'Hebron University Hospital, Barcelona, Spain; FSS Ltd, Kincraig, United Kingdom; University Hospital Kiel, Germany; Breast Cancer Center Vall d'Hebron University Hospital and SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Institut Jules Bordet and Breast European Adjuvant Study Team, Brussels, Belgium; Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru; Breast International Group, Brussels, Belgium; SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Breast European Adjuvant Study Team, Brussels, Belgium; GlaxoSmithKline, Collegeville, PA; European Institute of Oncology, Milan, Italy; National Cheng Kung University Hospital, Tainan, Taiwan; National Institute of Oncology, Budapest, Hungary; Academic Hospital of the University Charite, Berlin, Germany; Dana-Farber Cancer Institute, Boston, MA; Institut Jules Bordet, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"on Behalf of the NeoALTTO Study Team. Vall d'Hebron University Hospital, Barcelona, Spain; FSS Ltd, Kincraig, United Kingdom; University Hospital Kiel, Germany; Breast Cancer Center Vall d'Hebron University Hospital and SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Institut Jules Bordet and Breast European Adjuvant Study Team, Brussels, Belgium; Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru; Breast International Group, Brussels, Belgium; SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Breast European Adjuvant Study Team, Brussels, Belgium; GlaxoSmithKline, Collegeville, PA; European Institute of Oncology, Milan, Italy; National Cheng Kung University Hospital, Tainan, Taiwan; National Institute of Oncology, Budapest, Hungary; Academic Hospital of the University Charite, Berlin, Germany; Dana-Farber Cancer Institute, Boston, MA; Institut Jules Bordet, Brussels, Belgium","institution_ids":["https://openalex.org/I2801838318","https://openalex.org/I4210117453","https://openalex.org/I4210123325","https://openalex.org/I4210127641","https://openalex.org/I4210158999"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081663693","display_name":"Evandro de Azambuja","orcid":"https://orcid.org/0000-0001-9501-4509","observed_orcids":["https://orcid.org/0000-0001-9501-4509","https://orcid.org/0000-0001-7563-0179"]},"institutions":[{"id":"https://openalex.org/I2801838318","display_name":"Institut Jules Bordet","ror":"https://ror.org/05e8s8534","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2801838318"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210123325","display_name":"Instituto Nacional de Enfermedades Neopl\u00e1sicas","ror":"https://ror.org/03674y156","country_code":"PE","type":"healthcare","lineage":["https://openalex.org/I4210123325"]},{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]},{"id":"https://openalex.org/I4210158999","display_name":"National Cheng Kung University Hospital","ror":"https://ror.org/04zx3rq17","country_code":"TW","type":"healthcare","lineage":["https://openalex.org/I4210158999"]}],"countries":["BE","ES","PE","TW","US"],"is_corresponding":false,"raw_author_name":"E De Azambuja","raw_affiliation_strings":["on Behalf of the NeoALTTO Study Team. Vall d'Hebron University Hospital, Barcelona, Spain; FSS Ltd, Kincraig, United Kingdom; University Hospital Kiel, Germany; Breast Cancer Center Vall d'Hebron University Hospital and SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Institut Jules Bordet and Breast European Adjuvant Study Team, Brussels, Belgium; Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru; Breast International Group, Brussels, Belgium; SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Breast European Adjuvant Study Team, Brussels, Belgium; GlaxoSmithKline, Collegeville, PA; European Institute of Oncology, Milan, Italy; National Cheng Kung University Hospital, Tainan, Taiwan; National Institute of Oncology, Budapest, Hungary; Academic Hospital of the University Charite, Berlin, Germany; Dana-Farber Cancer Institute, Boston, MA; Institut Jules Bordet, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"on Behalf of the NeoALTTO Study Team. Vall d'Hebron University Hospital, Barcelona, Spain; FSS Ltd, Kincraig, United Kingdom; University Hospital Kiel, Germany; Breast Cancer Center Vall d'Hebron University Hospital and SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Institut Jules Bordet and Breast European Adjuvant Study Team, Brussels, Belgium; Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru; Breast International Group, Brussels, Belgium; SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Breast European Adjuvant Study Team, Brussels, Belgium; GlaxoSmithKline, Collegeville, PA; European Institute of Oncology, Milan, Italy; National Cheng Kung University Hospital, Tainan, Taiwan; National Institute of Oncology, Budapest, Hungary; Academic Hospital of the University Charite, Berlin, Germany; Dana-Farber Cancer Institute, Boston, MA; Institut Jules Bordet, Brussels, Belgium","institution_ids":["https://openalex.org/I2801838318","https://openalex.org/I4210117453","https://openalex.org/I4210123325","https://openalex.org/I4210127641","https://openalex.org/I4210158999"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049679970","display_name":"Henry G\u00f3mez","orcid":"https://orcid.org/0000-0002-3415-9701","observed_orcids":["https://orcid.org/0000-0002-3415-9701","https://orcid.org/0000-0003-2660-1843"]},"institutions":[{"id":"https://openalex.org/I2801838318","display_name":"Institut Jules Bordet","ror":"https://ror.org/05e8s8534","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2801838318"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210123325","display_name":"Instituto Nacional de Enfermedades Neopl\u00e1sicas","ror":"https://ror.org/03674y156","country_code":"PE","type":"healthcare","lineage":["https://openalex.org/I4210123325"]},{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]},{"id":"https://openalex.org/I4210158999","display_name":"National Cheng Kung University Hospital","ror":"https://ror.org/04zx3rq17","country_code":"TW","type":"healthcare","lineage":["https://openalex.org/I4210158999"]}],"countries":["BE","ES","PE","TW","US"],"is_corresponding":false,"raw_author_name":"H Gomez","raw_affiliation_strings":["on Behalf of the NeoALTTO Study Team. Vall d'Hebron University Hospital, Barcelona, Spain; FSS Ltd, Kincraig, United Kingdom; University Hospital Kiel, Germany; Breast Cancer Center Vall d'Hebron University Hospital and SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Institut Jules Bordet and Breast European Adjuvant Study Team, Brussels, Belgium; Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru; Breast International Group, Brussels, Belgium; SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Breast European Adjuvant Study Team, Brussels, Belgium; GlaxoSmithKline, Collegeville, PA; European Institute of Oncology, Milan, Italy; National Cheng Kung University Hospital, Tainan, Taiwan; National Institute of Oncology, Budapest, Hungary; Academic Hospital of the University Charite, Berlin, Germany; Dana-Farber Cancer Institute, Boston, MA; Institut Jules Bordet, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"on Behalf of the NeoALTTO Study Team. Vall d'Hebron University Hospital, Barcelona, Spain; FSS Ltd, Kincraig, United Kingdom; University Hospital Kiel, Germany; Breast Cancer Center Vall d'Hebron University Hospital and SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Institut Jules Bordet and Breast European Adjuvant Study Team, Brussels, Belgium; Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru; Breast International Group, Brussels, Belgium; SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Breast European Adjuvant Study Team, Brussels, Belgium; GlaxoSmithKline, Collegeville, PA; European Institute of Oncology, Milan, Italy; National Cheng Kung University Hospital, Tainan, Taiwan; National Institute of Oncology, Budapest, Hungary; Academic Hospital of the University Charite, Berlin, Germany; Dana-Farber Cancer Institute, Boston, MA; Institut Jules Bordet, Brussels, Belgium","institution_ids":["https://openalex.org/I2801838318","https://openalex.org/I4210117453","https://openalex.org/I4210123325","https://openalex.org/I4210127641","https://openalex.org/I4210158999"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085875414","display_name":"Phuong Dinh","orcid":"https://orcid.org/0000-0002-0273-1603","observed_orcids":["https://orcid.org/0000-0002-0273-1603"]},"institutions":[{"id":"https://openalex.org/I2801838318","display_name":"Institut Jules Bordet","ror":"https://ror.org/05e8s8534","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2801838318"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210123325","display_name":"Instituto Nacional de Enfermedades Neopl\u00e1sicas","ror":"https://ror.org/03674y156","country_code":"PE","type":"healthcare","lineage":["https://openalex.org/I4210123325"]},{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]},{"id":"https://openalex.org/I4210158999","display_name":"National Cheng Kung University Hospital","ror":"https://ror.org/04zx3rq17","country_code":"TW","type":"healthcare","lineage":["https://openalex.org/I4210158999"]}],"countries":["BE","ES","PE","TW","US"],"is_corresponding":false,"raw_author_name":"P Dinh","raw_affiliation_strings":["on Behalf of the NeoALTTO Study Team. Vall d'Hebron University Hospital, Barcelona, Spain; FSS Ltd, Kincraig, United Kingdom; University Hospital Kiel, Germany; Breast Cancer Center Vall d'Hebron University Hospital and SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Institut Jules Bordet and Breast European Adjuvant Study Team, Brussels, Belgium; Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru; Breast International Group, Brussels, Belgium; SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Breast European Adjuvant Study Team, Brussels, Belgium; GlaxoSmithKline, Collegeville, PA; European Institute of Oncology, Milan, Italy; National Cheng Kung University Hospital, Tainan, Taiwan; National Institute of Oncology, Budapest, Hungary; Academic Hospital of the University Charite, Berlin, Germany; Dana-Farber Cancer Institute, Boston, MA; Institut Jules Bordet, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"on Behalf of the NeoALTTO Study Team. Vall d'Hebron University Hospital, Barcelona, Spain; FSS Ltd, Kincraig, United Kingdom; University Hospital Kiel, Germany; Breast Cancer Center Vall d'Hebron University Hospital and SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Institut Jules Bordet and Breast European Adjuvant Study Team, Brussels, Belgium; Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru; Breast International Group, Brussels, Belgium; SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Breast European Adjuvant Study Team, Brussels, Belgium; GlaxoSmithKline, Collegeville, PA; European Institute of Oncology, Milan, Italy; National Cheng Kung University Hospital, Tainan, Taiwan; National Institute of Oncology, Budapest, Hungary; Academic Hospital of the University Charite, Berlin, Germany; Dana-Farber Cancer Institute, Boston, MA; Institut Jules Bordet, Brussels, Belgium","institution_ids":["https://openalex.org/I2801838318","https://openalex.org/I4210117453","https://openalex.org/I4210123325","https://openalex.org/I4210127641","https://openalex.org/I4210158999"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008974630","display_name":"Karine Fauria","orcid":"https://orcid.org/0000-0003-1506-4405","observed_orcids":["https://orcid.org/0000-0003-1506-4405"]},"institutions":[{"id":"https://openalex.org/I2801838318","display_name":"Institut Jules Bordet","ror":"https://ror.org/05e8s8534","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2801838318"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210123325","display_name":"Instituto Nacional de Enfermedades Neopl\u00e1sicas","ror":"https://ror.org/03674y156","country_code":"PE","type":"healthcare","lineage":["https://openalex.org/I4210123325"]},{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]},{"id":"https://openalex.org/I4210158999","display_name":"National Cheng Kung University Hospital","ror":"https://ror.org/04zx3rq17","country_code":"TW","type":"healthcare","lineage":["https://openalex.org/I4210158999"]}],"countries":["BE","ES","PE","TW","US"],"is_corresponding":false,"raw_author_name":"K Fauria","raw_affiliation_strings":["on Behalf of the NeoALTTO Study Team. Vall d'Hebron University Hospital, Barcelona, Spain; FSS Ltd, Kincraig, United Kingdom; University Hospital Kiel, Germany; Breast Cancer Center Vall d'Hebron University Hospital and SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Institut Jules Bordet and Breast European Adjuvant Study Team, Brussels, Belgium; Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru; Breast International Group, Brussels, Belgium; SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Breast European Adjuvant Study Team, Brussels, Belgium; GlaxoSmithKline, Collegeville, PA; European Institute of Oncology, Milan, Italy; National Cheng Kung University Hospital, Tainan, Taiwan; National Institute of Oncology, Budapest, Hungary; Academic Hospital of the University Charite, Berlin, Germany; Dana-Farber Cancer Institute, Boston, MA; Institut Jules Bordet, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"on Behalf of the NeoALTTO Study Team. Vall d'Hebron University Hospital, Barcelona, Spain; FSS Ltd, Kincraig, United Kingdom; University Hospital Kiel, Germany; Breast Cancer Center Vall d'Hebron University Hospital and SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Institut Jules Bordet and Breast European Adjuvant Study Team, Brussels, Belgium; Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru; Breast International Group, Brussels, Belgium; SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Breast European Adjuvant Study Team, Brussels, Belgium; GlaxoSmithKline, Collegeville, PA; European Institute of Oncology, Milan, Italy; National Cheng Kung University Hospital, Tainan, Taiwan; National Institute of Oncology, Budapest, Hungary; Academic Hospital of the University Charite, Berlin, Germany; Dana-Farber Cancer Institute, Boston, MA; Institut Jules Bordet, Brussels, Belgium","institution_ids":["https://openalex.org/I2801838318","https://openalex.org/I4210117453","https://openalex.org/I4210123325","https://openalex.org/I4210127641","https://openalex.org/I4210158999"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091754243","display_name":"Veerle Van Dooren","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801838318","display_name":"Institut Jules Bordet","ror":"https://ror.org/05e8s8534","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2801838318"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210123325","display_name":"Instituto Nacional de Enfermedades Neopl\u00e1sicas","ror":"https://ror.org/03674y156","country_code":"PE","type":"healthcare","lineage":["https://openalex.org/I4210123325"]},{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]},{"id":"https://openalex.org/I4210158999","display_name":"National Cheng Kung University Hospital","ror":"https://ror.org/04zx3rq17","country_code":"TW","type":"healthcare","lineage":["https://openalex.org/I4210158999"]}],"countries":["BE","ES","PE","TW","US"],"is_corresponding":false,"raw_author_name":"V Van Dooren","raw_affiliation_strings":["on Behalf of the NeoALTTO Study Team. Vall d'Hebron University Hospital, Barcelona, Spain; FSS Ltd, Kincraig, United Kingdom; University Hospital Kiel, Germany; Breast Cancer Center Vall d'Hebron University Hospital and SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Institut Jules Bordet and Breast European Adjuvant Study Team, Brussels, Belgium; Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru; Breast International Group, Brussels, Belgium; SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Breast European Adjuvant Study Team, Brussels, Belgium; GlaxoSmithKline, Collegeville, PA; European Institute of Oncology, Milan, Italy; National Cheng Kung University Hospital, Tainan, Taiwan; National Institute of Oncology, Budapest, Hungary; Academic Hospital of the University Charite, Berlin, Germany; Dana-Farber Cancer Institute, Boston, MA; Institut Jules Bordet, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"on Behalf of the NeoALTTO Study Team. Vall d'Hebron University Hospital, Barcelona, Spain; FSS Ltd, Kincraig, United Kingdom; University Hospital Kiel, Germany; Breast Cancer Center Vall d'Hebron University Hospital and SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Institut Jules Bordet and Breast European Adjuvant Study Team, Brussels, Belgium; Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru; Breast International Group, Brussels, Belgium; SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Breast European Adjuvant Study Team, Brussels, Belgium; GlaxoSmithKline, Collegeville, PA; European Institute of Oncology, Milan, Italy; National Cheng Kung University Hospital, Tainan, Taiwan; National Institute of Oncology, Budapest, Hungary; Academic Hospital of the University Charite, Berlin, Germany; Dana-Farber Cancer Institute, Boston, MA; Institut Jules Bordet, Brussels, Belgium","institution_ids":["https://openalex.org/I2801838318","https://openalex.org/I4210117453","https://openalex.org/I4210123325","https://openalex.org/I4210127641","https://openalex.org/I4210158999"]}]},{"author_position":"middle","author":{"id":null,"display_name":"P Paoletti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801838318","display_name":"Institut Jules Bordet","ror":"https://ror.org/05e8s8534","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2801838318"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210123325","display_name":"Instituto Nacional de Enfermedades Neopl\u00e1sicas","ror":"https://ror.org/03674y156","country_code":"PE","type":"healthcare","lineage":["https://openalex.org/I4210123325"]},{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]},{"id":"https://openalex.org/I4210158999","display_name":"National Cheng Kung University Hospital","ror":"https://ror.org/04zx3rq17","country_code":"TW","type":"healthcare","lineage":["https://openalex.org/I4210158999"]}],"countries":["BE","ES","PE","TW","US"],"is_corresponding":false,"raw_author_name":"P Paoletti","raw_affiliation_strings":["on Behalf of the NeoALTTO Study Team. Vall d'Hebron University Hospital, Barcelona, Spain; FSS Ltd, Kincraig, United Kingdom; University Hospital Kiel, Germany; Breast Cancer Center Vall d'Hebron University Hospital and SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Institut Jules Bordet and Breast European Adjuvant Study Team, Brussels, Belgium; Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru; Breast International Group, Brussels, Belgium; SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Breast European Adjuvant Study Team, Brussels, Belgium; GlaxoSmithKline, Collegeville, PA; European Institute of Oncology, Milan, Italy; National Cheng Kung University Hospital, Tainan, Taiwan; National Institute of Oncology, Budapest, Hungary; Academic Hospital of the University Charite, Berlin, Germany; Dana-Farber Cancer Institute, Boston, MA; Institut Jules Bordet, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"on Behalf of the NeoALTTO Study Team. Vall d'Hebron University Hospital, Barcelona, Spain; FSS Ltd, Kincraig, United Kingdom; University Hospital Kiel, Germany; Breast Cancer Center Vall d'Hebron University Hospital and SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Institut Jules Bordet and Breast European Adjuvant Study Team, Brussels, Belgium; Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru; Breast International Group, Brussels, Belgium; SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Breast European Adjuvant Study Team, Brussels, Belgium; GlaxoSmithKline, Collegeville, PA; European Institute of Oncology, Milan, Italy; National Cheng Kung University Hospital, Tainan, Taiwan; National Institute of Oncology, Budapest, Hungary; Academic Hospital of the University Charite, Berlin, Germany; Dana-Farber Cancer Institute, Boston, MA; Institut Jules Bordet, Brussels, Belgium","institution_ids":["https://openalex.org/I2801838318","https://openalex.org/I4210117453","https://openalex.org/I4210123325","https://openalex.org/I4210127641","https://openalex.org/I4210158999"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112472336","display_name":"Aron Goldhirsch","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801838318","display_name":"Institut Jules Bordet","ror":"https://ror.org/05e8s8534","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2801838318"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210123325","display_name":"Instituto Nacional de Enfermedades Neopl\u00e1sicas","ror":"https://ror.org/03674y156","country_code":"PE","type":"healthcare","lineage":["https://openalex.org/I4210123325"]},{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]},{"id":"https://openalex.org/I4210158999","display_name":"National Cheng Kung University Hospital","ror":"https://ror.org/04zx3rq17","country_code":"TW","type":"healthcare","lineage":["https://openalex.org/I4210158999"]}],"countries":["BE","ES","PE","TW","US"],"is_corresponding":false,"raw_author_name":"A Goldhirsch","raw_affiliation_strings":["on Behalf of the NeoALTTO Study Team. Vall d'Hebron University Hospital, Barcelona, Spain; FSS Ltd, Kincraig, United Kingdom; University Hospital Kiel, Germany; Breast Cancer Center Vall d'Hebron University Hospital and SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Institut Jules Bordet and Breast European Adjuvant Study Team, Brussels, Belgium; Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru; Breast International Group, Brussels, Belgium; SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Breast European Adjuvant Study Team, Brussels, Belgium; GlaxoSmithKline, Collegeville, PA; European Institute of Oncology, Milan, Italy; National Cheng Kung University Hospital, Tainan, Taiwan; National Institute of Oncology, Budapest, Hungary; Academic Hospital of the University Charite, Berlin, Germany; Dana-Farber Cancer Institute, Boston, MA; Institut Jules Bordet, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"on Behalf of the NeoALTTO Study Team. Vall d'Hebron University Hospital, Barcelona, Spain; FSS Ltd, Kincraig, United Kingdom; University Hospital Kiel, Germany; Breast Cancer Center Vall d'Hebron University Hospital and SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Institut Jules Bordet and Breast European Adjuvant Study Team, Brussels, Belgium; Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru; Breast International Group, Brussels, Belgium; SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Breast European Adjuvant Study Team, Brussels, Belgium; GlaxoSmithKline, Collegeville, PA; European Institute of Oncology, Milan, Italy; National Cheng Kung University Hospital, Tainan, Taiwan; National Institute of Oncology, Budapest, Hungary; Academic Hospital of the University Charite, Berlin, Germany; Dana-Farber Cancer Institute, Boston, MA; Institut Jules Bordet, Brussels, Belgium","institution_ids":["https://openalex.org/I2801838318","https://openalex.org/I4210117453","https://openalex.org/I4210123325","https://openalex.org/I4210127641","https://openalex.org/I4210158999"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079388488","display_name":"T-W Chang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801838318","display_name":"Institut Jules Bordet","ror":"https://ror.org/05e8s8534","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2801838318"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210123325","display_name":"Instituto Nacional de Enfermedades Neopl\u00e1sicas","ror":"https://ror.org/03674y156","country_code":"PE","type":"healthcare","lineage":["https://openalex.org/I4210123325"]},{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]},{"id":"https://openalex.org/I4210158999","display_name":"National Cheng Kung University Hospital","ror":"https://ror.org/04zx3rq17","country_code":"TW","type":"healthcare","lineage":["https://openalex.org/I4210158999"]}],"countries":["BE","ES","PE","TW","US"],"is_corresponding":false,"raw_author_name":"T-W Chang","raw_affiliation_strings":["on Behalf of the NeoALTTO Study Team. Vall d'Hebron University Hospital, Barcelona, Spain; FSS Ltd, Kincraig, United Kingdom; University Hospital Kiel, Germany; Breast Cancer Center Vall d'Hebron University Hospital and SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Institut Jules Bordet and Breast European Adjuvant Study Team, Brussels, Belgium; Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru; Breast International Group, Brussels, Belgium; SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Breast European Adjuvant Study Team, Brussels, Belgium; GlaxoSmithKline, Collegeville, PA; European Institute of Oncology, Milan, Italy; National Cheng Kung University Hospital, Tainan, Taiwan; National Institute of Oncology, Budapest, Hungary; Academic Hospital of the University Charite, Berlin, Germany; Dana-Farber Cancer Institute, Boston, MA; Institut Jules Bordet, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"on Behalf of the NeoALTTO Study Team. Vall d'Hebron University Hospital, Barcelona, Spain; FSS Ltd, Kincraig, United Kingdom; University Hospital Kiel, Germany; Breast Cancer Center Vall d'Hebron University Hospital and SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Institut Jules Bordet and Breast European Adjuvant Study Team, Brussels, Belgium; Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru; Breast International Group, Brussels, Belgium; SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Breast European Adjuvant Study Team, Brussels, Belgium; GlaxoSmithKline, Collegeville, PA; European Institute of Oncology, Milan, Italy; National Cheng Kung University Hospital, Tainan, Taiwan; National Institute of Oncology, Budapest, Hungary; Academic Hospital of the University Charite, Berlin, Germany; Dana-Farber Cancer Institute, Boston, MA; Institut Jules Bordet, Brussels, Belgium","institution_ids":["https://openalex.org/I2801838318","https://openalex.org/I4210117453","https://openalex.org/I4210123325","https://openalex.org/I4210127641","https://openalex.org/I4210158999"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112189754","display_name":"Istv\u00e1n L\u00e1ng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801838318","display_name":"Institut Jules Bordet","ror":"https://ror.org/05e8s8534","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2801838318"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210123325","display_name":"Instituto Nacional de Enfermedades Neopl\u00e1sicas","ror":"https://ror.org/03674y156","country_code":"PE","type":"healthcare","lineage":["https://openalex.org/I4210123325"]},{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]},{"id":"https://openalex.org/I4210158999","display_name":"National Cheng Kung University Hospital","ror":"https://ror.org/04zx3rq17","country_code":"TW","type":"healthcare","lineage":["https://openalex.org/I4210158999"]}],"countries":["BE","ES","PE","TW","US"],"is_corresponding":false,"raw_author_name":"I Lang","raw_affiliation_strings":["on Behalf of the NeoALTTO Study Team. Vall d'Hebron University Hospital, Barcelona, Spain; FSS Ltd, Kincraig, United Kingdom; University Hospital Kiel, Germany; Breast Cancer Center Vall d'Hebron University Hospital and SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Institut Jules Bordet and Breast European Adjuvant Study Team, Brussels, Belgium; Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru; Breast International Group, Brussels, Belgium; SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Breast European Adjuvant Study Team, Brussels, Belgium; GlaxoSmithKline, Collegeville, PA; European Institute of Oncology, Milan, Italy; National Cheng Kung University Hospital, Tainan, Taiwan; National Institute of Oncology, Budapest, Hungary; Academic Hospital of the University Charite, Berlin, Germany; Dana-Farber Cancer Institute, Boston, MA; Institut Jules Bordet, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"on Behalf of the NeoALTTO Study Team. Vall d'Hebron University Hospital, Barcelona, Spain; FSS Ltd, Kincraig, United Kingdom; University Hospital Kiel, Germany; Breast Cancer Center Vall d'Hebron University Hospital and SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Institut Jules Bordet and Breast European Adjuvant Study Team, Brussels, Belgium; Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru; Breast International Group, Brussels, Belgium; SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Breast European Adjuvant Study Team, Brussels, Belgium; GlaxoSmithKline, Collegeville, PA; European Institute of Oncology, Milan, Italy; National Cheng Kung University Hospital, Tainan, Taiwan; National Institute of Oncology, Budapest, Hungary; Academic Hospital of the University Charite, Berlin, Germany; Dana-Farber Cancer Institute, Boston, MA; Institut Jules Bordet, Brussels, Belgium","institution_ids":["https://openalex.org/I2801838318","https://openalex.org/I4210117453","https://openalex.org/I4210123325","https://openalex.org/I4210127641","https://openalex.org/I4210158999"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003405177","display_name":"Michael Untch","orcid":"https://orcid.org/0000-0002-1233-1267","observed_orcids":["https://orcid.org/0000-0002-1233-1267"]},"institutions":[{"id":"https://openalex.org/I2801838318","display_name":"Institut Jules Bordet","ror":"https://ror.org/05e8s8534","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2801838318"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210123325","display_name":"Instituto Nacional de Enfermedades Neopl\u00e1sicas","ror":"https://ror.org/03674y156","country_code":"PE","type":"healthcare","lineage":["https://openalex.org/I4210123325"]},{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]},{"id":"https://openalex.org/I4210158999","display_name":"National Cheng Kung University Hospital","ror":"https://ror.org/04zx3rq17","country_code":"TW","type":"healthcare","lineage":["https://openalex.org/I4210158999"]}],"countries":["BE","ES","PE","TW","US"],"is_corresponding":false,"raw_author_name":"M Untch","raw_affiliation_strings":["on Behalf of the NeoALTTO Study Team. Vall d'Hebron University Hospital, Barcelona, Spain; FSS Ltd, Kincraig, United Kingdom; University Hospital Kiel, Germany; Breast Cancer Center Vall d'Hebron University Hospital and SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Institut Jules Bordet and Breast European Adjuvant Study Team, Brussels, Belgium; Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru; Breast International Group, Brussels, Belgium; SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Breast European Adjuvant Study Team, Brussels, Belgium; GlaxoSmithKline, Collegeville, PA; European Institute of Oncology, Milan, Italy; National Cheng Kung University Hospital, Tainan, Taiwan; National Institute of Oncology, Budapest, Hungary; Academic Hospital of the University Charite, Berlin, Germany; Dana-Farber Cancer Institute, Boston, MA; Institut Jules Bordet, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"on Behalf of the NeoALTTO Study Team. Vall d'Hebron University Hospital, Barcelona, Spain; FSS Ltd, Kincraig, United Kingdom; University Hospital Kiel, Germany; Breast Cancer Center Vall d'Hebron University Hospital and SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Institut Jules Bordet and Breast European Adjuvant Study Team, Brussels, Belgium; Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru; Breast International Group, Brussels, Belgium; SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Breast European Adjuvant Study Team, Brussels, Belgium; GlaxoSmithKline, Collegeville, PA; European Institute of Oncology, Milan, Italy; National Cheng Kung University Hospital, Tainan, Taiwan; National Institute of Oncology, Budapest, Hungary; Academic Hospital of the University Charite, Berlin, Germany; Dana-Farber Cancer Institute, Boston, MA; Institut Jules Bordet, Brussels, Belgium","institution_ids":["https://openalex.org/I2801838318","https://openalex.org/I4210117453","https://openalex.org/I4210123325","https://openalex.org/I4210127641","https://openalex.org/I4210158999"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040290360","display_name":"Richard D. Gelber","orcid":"https://orcid.org/0000-0001-8270-8712","observed_orcids":["https://orcid.org/0000-0001-8270-8712"]},"institutions":[{"id":"https://openalex.org/I2801838318","display_name":"Institut Jules Bordet","ror":"https://ror.org/05e8s8534","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2801838318"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210123325","display_name":"Instituto Nacional de Enfermedades Neopl\u00e1sicas","ror":"https://ror.org/03674y156","country_code":"PE","type":"healthcare","lineage":["https://openalex.org/I4210123325"]},{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]},{"id":"https://openalex.org/I4210158999","display_name":"National Cheng Kung University Hospital","ror":"https://ror.org/04zx3rq17","country_code":"TW","type":"healthcare","lineage":["https://openalex.org/I4210158999"]}],"countries":["BE","ES","PE","TW","US"],"is_corresponding":false,"raw_author_name":"RD Gelber","raw_affiliation_strings":["on Behalf of the NeoALTTO Study Team. Vall d'Hebron University Hospital, Barcelona, Spain; FSS Ltd, Kincraig, United Kingdom; University Hospital Kiel, Germany; Breast Cancer Center Vall d'Hebron University Hospital and SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Institut Jules Bordet and Breast European Adjuvant Study Team, Brussels, Belgium; Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru; Breast International Group, Brussels, Belgium; SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Breast European Adjuvant Study Team, Brussels, Belgium; GlaxoSmithKline, Collegeville, PA; European Institute of Oncology, Milan, Italy; National Cheng Kung University Hospital, Tainan, Taiwan; National Institute of Oncology, Budapest, Hungary; Academic Hospital of the University Charite, Berlin, Germany; Dana-Farber Cancer Institute, Boston, MA; Institut Jules Bordet, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"on Behalf of the NeoALTTO Study Team. Vall d'Hebron University Hospital, Barcelona, Spain; FSS Ltd, Kincraig, United Kingdom; University Hospital Kiel, Germany; Breast Cancer Center Vall d'Hebron University Hospital and SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Institut Jules Bordet and Breast European Adjuvant Study Team, Brussels, Belgium; Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru; Breast International Group, Brussels, Belgium; SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Breast European Adjuvant Study Team, Brussels, Belgium; GlaxoSmithKline, Collegeville, PA; European Institute of Oncology, Milan, Italy; National Cheng Kung University Hospital, Tainan, Taiwan; National Institute of Oncology, Budapest, Hungary; Academic Hospital of the University Charite, Berlin, Germany; Dana-Farber Cancer Institute, Boston, MA; Institut Jules Bordet, Brussels, Belgium","institution_ids":["https://openalex.org/I2801838318","https://openalex.org/I4210117453","https://openalex.org/I4210123325","https://openalex.org/I4210127641","https://openalex.org/I4210158999"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5087380706","display_name":"Martine J Piccart","orcid":"https://orcid.org/0000-0001-9068-8504","observed_orcids":["https://orcid.org/0000-0001-9068-8504"]},"institutions":[{"id":"https://openalex.org/I2801838318","display_name":"Institut Jules Bordet","ror":"https://ror.org/05e8s8534","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2801838318"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210123325","display_name":"Instituto Nacional de Enfermedades Neopl\u00e1sicas","ror":"https://ror.org/03674y156","country_code":"PE","type":"healthcare","lineage":["https://openalex.org/I4210123325"]},{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]},{"id":"https://openalex.org/I4210158999","display_name":"National Cheng Kung University Hospital","ror":"https://ror.org/04zx3rq17","country_code":"TW","type":"healthcare","lineage":["https://openalex.org/I4210158999"]}],"countries":["BE","ES","PE","TW","US"],"is_corresponding":false,"raw_author_name":"M Piccart-Gebhart","raw_affiliation_strings":["on Behalf of the NeoALTTO Study Team. Vall d'Hebron University Hospital, Barcelona, Spain; FSS Ltd, Kincraig, United Kingdom; University Hospital Kiel, Germany; Breast Cancer Center Vall d'Hebron University Hospital and SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Institut Jules Bordet and Breast European Adjuvant Study Team, Brussels, Belgium; Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru; Breast International Group, Brussels, Belgium; SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Breast European Adjuvant Study Team, Brussels, Belgium; GlaxoSmithKline, Collegeville, PA; European Institute of Oncology, Milan, Italy; National Cheng Kung University Hospital, Tainan, Taiwan; National Institute of Oncology, Budapest, Hungary; Academic Hospital of the University Charite, Berlin, Germany; Dana-Farber Cancer Institute, Boston, MA; Institut Jules Bordet, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"on Behalf of the NeoALTTO Study Team. Vall d'Hebron University Hospital, Barcelona, Spain; FSS Ltd, Kincraig, United Kingdom; University Hospital Kiel, Germany; Breast Cancer Center Vall d'Hebron University Hospital and SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Institut Jules Bordet and Breast European Adjuvant Study Team, Brussels, Belgium; Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru; Breast International Group, Brussels, Belgium; SOLTI (Spanish Breast Cancer Research Group), Barcelona, Spain; Breast European Adjuvant Study Team, Brussels, Belgium; GlaxoSmithKline, Collegeville, PA; European Institute of Oncology, Milan, Italy; National Cheng Kung University Hospital, Tainan, Taiwan; National Institute of Oncology, Budapest, Hungary; Academic Hospital of the University Charite, Berlin, Germany; Dana-Farber Cancer Institute, Boston, MA; Institut Jules Bordet, Brussels, Belgium","institution_ids":["https://openalex.org/I2801838318","https://openalex.org/I4210117453","https://openalex.org/I4210123325","https://openalex.org/I4210127641","https://openalex.org/I4210158999"]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":117,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"70","issue":"24_Supplement","first_page":"S3","last_page":"3"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9804999828338623,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9804999828338623,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.0142000000923872,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.0020000000949949026,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/neoaltto-trial","display_name":"NeoALTTO trial","score":0.8650000095367432},{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.9589999914169312},{"id":"https://openalex.org/keywords/neoadjuvant-chemotherapy","display_name":"neoadjuvant chemotherapy","score":0.8289999961853027},{"id":"https://openalex.org/keywords/lapatinib","display_name":"lapatinib","score":0.9909999966621399},{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":1.0},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.9879999756813049},{"id":"https://openalex.org/keywords/pathological-complete-response","display_name":"pathological complete response","score":0.9330000281333923},{"id":"https://openalex.org/keywords/her2-targeted-therapy","display_name":"HER2-targeted therapy","score":0.6930000185966492},{"id":"https://openalex.org/keywords/adjuvant-therapy","display_name":"adjuvant therapy","score":0.4909999966621399},{"id":"https://openalex.org/keywords/her2-positive-metastatic-breast-cancer","display_name":"HER2-positive metastatic breast cancer","score":0.5540000200271606},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.3179999887943268},{"id":"https://openalex.org/keywords/egfr-tyrosine-kinase-inhibitors","display_name":"EGFR tyrosine kinase inhibitors","score":0.6010000109672546},{"id":"https://openalex.org/keywords/her2-tyrosine-kinase-inhibitor","display_name":"HER2 tyrosine kinase inhibitor","score":0.5699999928474426}],"concepts":[{"id":"https://openalex.org/C2777329042","wikidata":"https://www.wikidata.org/wiki/Q420323","display_name":"Lapatinib","level":5,"score":0.9738236665725708},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.9190261960029602},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8913400173187256},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.6258037090301514},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6149823665618896},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6023396253585815},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5915004014968872},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5302067995071411},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.4912187457084656},{"id":"https://openalex.org/C2778292576","wikidata":"https://www.wikidata.org/wiki/Q6991934","display_name":"Neoadjuvant therapy","level":4,"score":0.45556995272636414},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4206865429878235},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.361477255821228},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.32111334800720215}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/0008-5472.sabcs10-s3-3","doi":"https://doi.org/10.1158/0008-5472.sabcs10-s3-3","is_oa":false,"landing_page_url":"https://doi.org/10.1158/0008-5472.sabcs10-s3-3","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2111578514","https://openalex.org/W2155560234","https://openalex.org/W2060796180","https://openalex.org/W2055235037","https://openalex.org/W3092223910","https://openalex.org/W67104293","https://openalex.org/W1748137726","https://openalex.org/W2965526302","https://openalex.org/W2943571483","https://openalex.org/W2123496271"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"The":[2,62,246,336],"addition":[3],"of":[4,69,101,174,207,216,230,243,249,263,269,278,291,317,324,364],"trastuzumab":[5,50,71,106,113,151,170],"to":[6,128,142,253,293],"neoadjuvant":[7,81,118,204,232],"chemotherapy":[8,33],"has":[9,34],"significantly":[10,35],"improved":[11,36,51],"pathological":[12],"complete":[13,240,351],"response":[14,284],"(pCR)":[15,363],"in":[16,40,56,83,120,226,272,328,342],"patients":[17,41,57,84,132,183,212,302,325],"with":[18,32,42,49,58,76,85,169],"HER2-positive":[19,44,60,86],"early":[20],"breast":[21,274,294,338],"cancer":[22,271],"(BC).":[23],"Lapatinib,":[24],"a":[25,172,196,235],"dual":[26],"HER2/EGFR":[27],"tyrosine":[28],"kinase":[29],"inhibitor,":[30],"combined":[31,48],"progression":[37],"free":[38],"survival":[39,55,297],"metastatic":[43,59],"BC.":[45,61,87,124],"Additionally,":[46],"lapatinib":[47,102,111,145,166],"disease-free":[52,296],"and":[53,89,112,255,298,313,330,347,355,359],"overall":[54,299],"NeoALTTO":[63,91],"trial":[64,369],"is":[65,92,252],"testing":[66],"the":[67,99,186,221,227,231,250,258,261,267,273,276,318,360,374],"efficacy":[68,100],"lapatinib,":[70],"or":[72,150,165],"their":[73],"combination":[74],"together":[75],"paclitaxel":[77,115,192],"when":[78],"given":[79,116],"as":[80,117,225,266],"therapy":[82,189,205,224,312,320],"Material":[88],"Methods:":[90],"an":[93],"international,":[94],"multicenter,":[95],"randomized":[96,134,141],"study":[97,251],"comparing":[98],"plus":[103,107,114,190],"paclitaxel,":[104,108],"versus":[105,109],"concomitant":[110],"treatment":[119],"HER2-":[121],"positive":[122],"primary":[123,247,361],"From":[125],"January,":[126],"2008,":[127],"December,":[129],"2009,":[130],"455":[131],"were":[133,140],"from":[135],"99":[136],"participating":[137],"sites.":[138],"Patients":[139],"receive":[143],"either":[144],"1500":[146],"mg/d":[147,168],"(154":[148],"pts),":[149,164],"4":[152],"mg/kg":[153,160],"IV":[154,161],"loading":[155],"dose":[156],"followed":[157,219],"by":[158,220,352],"2":[159],"weekly":[162,191],"(149":[163],"1000":[167],"for":[171,195,234,306,357],"total":[173],"6":[175],"weeks":[176,238,242],"(152":[177],"pts).":[178],"After":[179,210],"this":[180,365],"biological":[181,228,319],"window,":[182],"continued":[184],"on":[185,314],"same":[187,222],"targeted":[188,223],"80":[193],"mg/m2":[194],"further":[197,236],"12":[198],"weeks,":[199],"until":[200],"definitive":[201],"surgery":[202,339],"(total":[203],"duration":[206],"18":[208],"weeks).":[209],"surgery,":[211],"received":[213],"3":[214],"cycles":[215],"adjuvant":[217],"FEC":[218],"window":[229],"phase":[233,367],"34":[237],"(to":[239],"52":[241],"anti-HER2":[244],"therapy).":[245],"objective":[248,283,362],"evaluate":[254],"compare":[256],"among":[257],"three":[259],"arms":[260],"rate":[262,290],"pCR,":[264],"defined":[265],"absence":[268],"invasive":[270],"at":[275,373],"time":[277],"surgery.":[279],"Secondary":[280],"objectives":[281],"include":[282],"rate,":[285],"safety,":[286],"pathologic":[287],"node-negative":[288],"status,":[289],"conversion":[292],"conservation,":[295],"survival.":[300],"All":[301],"underwent":[303],"tumor":[304,332],"biopsies":[305],"comparative":[307],"pharmacodynamic":[308],"analyses":[309],"before":[310],"beginning":[311],"day":[315],"15":[316],"window.":[321],"A":[322],"subset":[323],"also":[326],"participated":[327],"PET/CT":[329],"circulating":[331],"cells":[333],"substudies.":[334],"Results:":[335],"last":[337],"was":[340],"performed":[341],"May":[343],"2010.":[344],"Data":[345],"cleaning":[346],"analysis":[348],"will":[349,370],"be":[350,371],"November":[353],"2010":[354],"results":[356],"safety":[358],"important":[366],"III":[368],"presented":[372],"meeting.":[375],"Citation":[376],"Information:":[377],"Cancer":[378],"Res":[379],"2010;70(24":[380],"Suppl):Abstract":[381],"nr":[382],"S3-3.":[383]},"counts_by_year":[{"year":2021,"cited_by_count":4},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":3},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":46}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}